Alivus Life Sciences has allotted 52,200 Equity Shares, each with a face value of Rs. 2, to eligible employees who exercised their stock options.

This move increases the company's paid-up share capital from 12,26,29,148 equity shares (aggregating Rs. 24,52,58,296) to 12,26,81,348 equity shares (aggregating Rs. 24,53,62,696). This slight increase in capital reflects enhanced employee ownership and aligns incentives.